Intra-articular injection of autologous tolerogenic dendritic cells modifies the synovial immune landscape in rheumatoid and inflammatory arthritis
Annals of the Rheumatic Diseases · 2026-08 · 85 (8) · 1477-1485
DOI: 10.1016/j.ard.2026.01.004 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of the Rheumatic Diseases, 2026-08. Verfasst von Ioana Nicorescu und 16 weiteren Autor:innen. Beteiligte Einrichtung: Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK. Hauptthemen laut MEDLINE: Dendritic Cells, Synovial Membrane, Immune Tolerance, Arthritis, Rheumatoid. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: JGW Patterson Foundation, European Commission Marie Sklodowska-Curie Actions, Horizon 2020 Framework Programme.
Abstract (Originalsprache)
OBJECTIVES: In our previously reported trial of intra-articular tolerogenic dendritic cells (tolDC) as a treatment to restore immune tolerance in autoimmune arthritis, high doses of cells appeared to stabilise knee symptoms, although no systemic clinical or immunomodulatory effects were observed. We therefore sought to understand how tolDC affected the local synovial immune landscape. METHODS: Synovial biopsies were taken at baseline and 14 days after intra-articular injection of tolDC or, as a control, saline washout. Histopathological analyses (Krenn evaluation and pathotype) and multiparametric imaging mass cytometry (IMC) were performed on paired synovial tissues from 7 participants (5 tolDC-treated and 2 controls), selected based on tissue availability at both time points. The IMC panel included 27 antibodies defining lymphoid, myeloid, and stromal cells. RESULTS: We observed no changes in the histopathology or the overall distribution of broadly classified cell populations (myeloid, lymphoid, and stromal) before and after tolDC administration. Furthermore, the proportions of CD4+ and CD8+ T cells were not altered, with no indication that tolDC had induced regulatory T cells within the synovium. However, we found a significant increase in a subset of myeloid cells expressing high levels of the inflammation resolution marker Mer tyrosine kinase (MerTKHigh), which positively correlated with tolDC dose. Moreover, the percentages of total MerTK+ myeloid cells inversely correlated with arthroscopic synovitis scores at both time points. CONCLUSIONS: The tolDC-induced increase in synovial Myeloid MerTKHigh cells may have local immune modulatory effects and provide promising evidence for an effect of tolDC treatment on the synovial immune landscape.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK.
- Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK; Flow Cytometry Core Facility, Faculty of Medical Sciences, Newcastle University, Newcastle upon…
- Biosciences Institute, Innovation, Methodology and Application (IMA) Research Theme, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK; Image Analysis Unit, Faculty of Medical Sciences, Newcastl…
- Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK; National Institute for Health Research (NIHR) Newcastle Biomedical Research Centre and NIHR Clin…
- Research into Inflammatory Arthritis Centre Versus Arthritis (RACE), UK; School of Infection and Immunity, University of Glasgow, Glasgow, UK.
- Research into Inflammatory Arthritis Centre Versus Arthritis (RACE), UK; National Institute for Health Research (NIHR) Birmingham Biomedical Research Centre and NIHR Clinical Research Facility, University Hospitals Birm…
Förderung
- JGW Patterson Foundation
- European Commission Marie Sklodowska-Curie Actions
- Horizon 2020 Framework Programme
- Birmingham Biomedical Research Centre
- Versus Arthritis
- NIHR Newcastle Biomedical Research Centre
- National Institute for Health and Care Research
Zitieren
APA
Nicorescu, I., Thomson, A., Merces, G., Harrison, J. F., Barron-Millar, B., Pratt, A. G., Anderson, A. E., Diboll, J., Rankin, K. S., Somma, D., Kurowska-Stolarska, M., Jones, L. J., Filer, A., McDonald, D., Filby, A., Isaacs, J. D., & Hilkens, C. M. U. (2026). Intra-articular injection of autologous tolerogenic dendritic cells modifies the synovial immune landscape in rheumatoid and inflammatory arthritis. Annals of the Rheumatic Diseases, 85(8), 1477-1485. https://doi.org/10.1016/j.ard.2026.01.004
Vancouver
Nicorescu I, Thomson A, Merces G, Harrison JF, Barron-Millar B, Pratt AG, et al. Intra-articular injection of autologous tolerogenic dendritic cells modifies the synovial immune landscape in rheumatoid and inflammatory arthritis. Annals of the Rheumatic Diseases. 2026;85(8):1477-1485. doi:10.1016/j.ard.2026.01.004
BibTeX
@article{Nicorescu2026,
author = {Nicorescu, Ioana and Thomson, Amanda and Merces, George and Harrison, Jack F and Barron-Millar, Ben and Pratt, Arthur G and Anderson, Amy E and Diboll, Julie and Rankin, Kenneth S and Somma, Domenico and Kurowska-Stolarska, Mariola and Jones, Luke J and Filer, Andrew and McDonald, David and Filby, Andrew and Isaacs, John D and Hilkens, Catharien M U},
title = {Intra-articular injection of autologous tolerogenic dendritic cells modifies the synovial immune landscape in rheumatoid and inflammatory arthritis},
journal = {Annals of the Rheumatic Diseases},
year = {2026},
volume = {85},
number = {8},
pages = {1477--1485},
doi = {10.1016/j.ard.2026.01.004}
}
EUVIMED